Form 8-K - Current report:
SEC Accession No. 0001193125-21-121301
Filing Date
2021-04-19
Accepted
2021-04-19 16:30:03
Documents
14
Period of Report
2021-04-19
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d106917d8k.htm   iXBRL 8-K 24631
2 EX-99.1 d106917dex991.htm EX-99.1 10677
6 GRAPHIC g106917g0419024320802.jpg GRAPHIC 2735
  Complete submission text file 0001193125-21-121301.txt   169435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zlab-20210419.xsd EX-101.SCH 3052
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlab-20210419_lab.xml EX-101.LAB 18840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlab-20210419_pre.xml EX-101.PRE 11827
7 EXTRACTED XBRL INSTANCE DOCUMENT d106917d8k_htm.xml XML 3561
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 21834962
SIC: 2834 Pharmaceutical Preparations